Effects of clonidine on habituation and sensitization of acoustic startle in normal, decerebrate and locus coeruleus lesioned rats. 1977

M Davis, and J M Cedarbaum, and G K Aghajanian, and D S Gendelman

Rats were presented with startle-eliciting tones after injection of clonidine (0.01, 0.02, 0.04, 0.08, 0.5, 1.0 or 2.0 mg/kg) or saline. Clonidine potently depressed startle amplitude and the effect was monotonically related todose. Pretreatment with piperoxane (10 mg/kg) antagonized this effect but pretreatment with phentolamine (10 mg/kg) did not. Clonidine still depressed startle in acutely decerebrate rats and in rats with bilateral ablation of the locus coeruleus. Clonidine did not interfere with sensitization to background noise and did not interfere with the ability to startle but instead improved within-session habituation. The results represent one of the few instances in the literature where a drug appears to improve habituation without directly interfering with the ability to respond. The possibility that clonidine might affect startle by stimulating central epinephrine rather than norepinephrine receptors is discussed.

UI MeSH Term Description Entries
D008297 Male Males
D010646 Phentolamine A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease. Fentolamin,Phentolamine Mesilate,Phentolamine Mesylate,Phentolamine Methanesulfonate,Phentolamine Mono-hydrochloride,Regitine,Regityn,Rogitine,Z-Max,Mesilate, Phentolamine,Mesylate, Phentolamine,Methanesulfonate, Phentolamine,Mono-hydrochloride, Phentolamine,Phentolamine Mono hydrochloride
D010883 Piperoxan A benzodioxane alpha-adrenergic blocking agent with considerable stimulatory action. It has been used to diagnose PHEOCHROMOCYTOMA and as an antihypertensive agent. Benodain,Benodaine,Forneau 933,Piperoxane
D002552 Cerebral Ventricles Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE). Foramen of Monro,Cerebral Ventricular System,Cerebral Ventricle,Cerebral Ventricular Systems,Monro Foramen,System, Cerebral Ventricular,Systems, Cerebral Ventricular,Ventricle, Cerebral,Ventricles, Cerebral,Ventricular System, Cerebral,Ventricular Systems, Cerebral
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D003655 Decerebrate State A condition characterized by abnormal posturing of the limbs that is associated with injury to the brainstem. This may occur as a clinical manifestation or induced experimentally in animals. The extensor reflexes are exaggerated leading to rigid extension of the limbs accompanied by hyperreflexia and opisthotonus. This condition is usually caused by lesions which occur in the region of the brainstem that lies between the red nuclei and the vestibular nuclei. In contrast, decorticate rigidity is characterized by flexion of the elbows and wrists with extension of the legs and feet. The causative lesion for this condition is located above the red nuclei and usually consists of diffuse cerebral damage. (From Adams et al., Principles of Neurology, 6th ed, p358) Decerebrate Posturing,Decorticate Rigidity,Decorticate State,Rigidity, Decerebrate,Rigidity, Decorticate,Decerebrate Posturings,Decerebrate Rigidity,Decerebrate States,Decorticate Rigidities,Decorticate States,Posturing, Decerebrate,Posturings, Decerebrate,Rigidities, Decorticate,State, Decerebrate,States, Decerebrate
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006185 Habituation, Psychophysiologic The disappearance of responsiveness to a repeated stimulation. It does not include drug habituation. Habituation (Psychophysiology),Habituation, Psychophysiological,Psychophysiologic Habituation,Psychophysiological Habituation,Habituations (Psychophysiology)
D000161 Acoustic Stimulation Use of sound to elicit a response in the nervous system. Auditory Stimulation,Stimulation, Acoustic,Stimulation, Auditory
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M Davis, and J M Cedarbaum, and G K Aghajanian, and D S Gendelman
July 1975, Psychopharmacologia,
M Davis, and J M Cedarbaum, and G K Aghajanian, and D S Gendelman
October 1985, Behavioral neuroscience,
M Davis, and J M Cedarbaum, and G K Aghajanian, and D S Gendelman
February 1976, European journal of pharmacology,
M Davis, and J M Cedarbaum, and G K Aghajanian, and D S Gendelman
June 1976, Physiology & behavior,
M Davis, and J M Cedarbaum, and G K Aghajanian, and D S Gendelman
August 1978, The Journal of physiology,
M Davis, and J M Cedarbaum, and G K Aghajanian, and D S Gendelman
January 1981, Psychopharmacology,
M Davis, and J M Cedarbaum, and G K Aghajanian, and D S Gendelman
March 1989, Psychophysiology,
M Davis, and J M Cedarbaum, and G K Aghajanian, and D S Gendelman
July 1996, Neurobiology of learning and memory,
M Davis, and J M Cedarbaum, and G K Aghajanian, and D S Gendelman
June 1984, Pharmacology, biochemistry, and behavior,
M Davis, and J M Cedarbaum, and G K Aghajanian, and D S Gendelman
October 1982, Japanese journal of pharmacology,
Copied contents to your clipboard!